Revolutionizing in vitro preclinical screening
3Brain's CorePlate™ 6W 38/60 is the next-gen multiwell drug-screening platform to monitor simultaneously and in real time thousands of electrically active cells (e.g. neurons, cardiac cells, organoids).
Each well integrates our patented bio-signal processing unit, an advanced microchip sensor designed to provide unprecedented quality results from drug screenings and neurotoxicity assay.
Label-free measurements
Real-time monitoring of the electrical activity of thousands of cells simultaneously - without the necessity to use dyes or indicators (e.g. voltage sensitive dyes or Ca2+ sensors) - allows to grab all the details of the functional alteration induced at the network scale by a tested compound.
Less experiments, better results
3Brain’s technology provides high-quality, high-content data, thus improving the efficiency of your assay by reducing the number of experiments needed and accelerating the time to results.
High quality kinetic phenotypic assay
With 3Brain’s label-free technology, your kinetic assays are not limited to end-point measurements. The same biological sample can be monitored over long times (days, weeks, months) to assess acute as well as long term effects of the tested compounds.
Unprecedented statistical significance
The thousands of simultaneously monitored cells per well provide a more comprehensive and richer data set compared to systems with lower number of measuring points, thus fully exploiting the tested biological model and improving the statistical significance of each single point of the assay.
Click here to know how the technology works
Feel free to get in contact with our neuroscientists team for details
Contact UsLocation to specific products and samples within 3Brain's resources
Cradle. (2024).
(paper)
Cell Stem Cell (2024). DOI: 10.1016/j.stem.2024.08.004
(paper)
Nature (2024). DOI: 10.1038/s41586-024-07578-8